Skip to Main Content
Skip Nav Destination

Issues

Acta Haematologica 2021, Vol. 144, No. 4

Editorial Comment

Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (4): 355–359. https://doi.org/10.1159/000510352

Systematic Review

Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (4): 360–364. https://doi.org/10.1159/000510914

Review

Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (4): 365–379. https://doi.org/10.1159/000510768
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (4): 380–388. https://doi.org/10.1159/000510980
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (4): 389–402. https://doi.org/10.1159/000511208
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (4): 403–412. https://doi.org/10.1159/000511759
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (4): 413–417. https://doi.org/10.1159/000511760

Original Paper

Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (4): 418–426. https://doi.org/10.1159/000510676
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (4): 427–437. https://doi.org/10.1159/000510912
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (4): 438–445. https://doi.org/10.1159/000511426
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (4): 446–457. https://doi.org/10.1159/000511551

Brief Communication

Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (4): 458–464. https://doi.org/10.1159/000511953

Case Report

Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (4): 465–469. https://doi.org/10.1159/000510913

Erratum

Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (4): 470. https://doi.org/10.1159/000511803

Pharma News

Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (4): 471–472. https://doi.org/10.1159/000518282
Close Modal

or Create an Account

Close Modal
Close Modal